Innovating Works
SEC-05-DRS-2016-2017
SEC-05-DRS-2016-2017: Chemical, biological, radiological and nuclear (CBRN) cluster
Specific Challenge:Technologies and innovations in the field of CBRN are developed by SMEs or larger companies which often face difficulties in bringing them to markets: because they address local, small niche markets; or because these SMEs have neither the capabilities nor the strategic objective to go for foreign markets; or because the individual technologies that they develop can make it to the market only if integrated and combined with other tools by other companies that have the capabilities and the strategy to market its products abroad, and possibly on the global market.
Sólo fondo perdido 14M €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 25-08-2016.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Número mínimo de participantes.
Esta ayuda financia Proyectos: Objetivo del proyecto:

Specific Challenge:Technologies and innovations in the field of CBRN are developed by SMEs or larger companies which often face difficulties in bringing them to markets: because they address local, small niche markets; or because these SMEs have neither the capabilities nor the strategic objective to go for foreign markets; or because the individual technologies that they develop can make it to the market only if integrated and combined with other tools by other companies that have the capabilities and the strategy to market its products abroad, and possibly on the global market.

Such synergies among companies are not frequent in the area of CBRN technologies, which is to the detriment of industrial competitiveness, and which limits considerably the offer made to the practitioners if one compares with the actual technological state-of-the-art.


Scope:A CBRN cluster could articulate two kinds of actions:

Part a) (2016): A CSA supported by a "complementary grant"[1] will gather the largest number of European companies capable and willing to market their products globally (e.g. companies producing integrated equipment for First Re... ver más

Specific Challenge:Technologies and innovations in the field of CBRN are developed by SMEs or larger companies which often face difficulties in bringing them to markets: because they address local, small niche markets; or because these SMEs have neither the capabilities nor the strategic objective to go for foreign markets; or because the individual technologies that they develop can make it to the market only if integrated and combined with other tools by other companies that have the capabilities and the strategy to market its products abroad, and possibly on the global market.

Such synergies among companies are not frequent in the area of CBRN technologies, which is to the detriment of industrial competitiveness, and which limits considerably the offer made to the practitioners if one compares with the actual technological state-of-the-art.


Scope:A CBRN cluster could articulate two kinds of actions:

Part a) (2016): A CSA supported by a "complementary grant"[1] will gather the largest number of European companies capable and willing to market their products globally (e.g. companies producing integrated equipment for First Responder's, CBRN software systems, detectors, decontaminators, waste management and encapsulation equipment). The participants in the CSA will provide platforms (toolkits and systems in the field of CBRN) in which to integrate the technologies and innovations developed by other companies under Part B). They will develop interfaces with financial institutions potentially interested in the sector, including through InnovFin instruments and accompanying measures. [2] The CSA will issue a list of technologies that need to be developed with a view to integrating them into the platforms, possibly building upon the inventory developed by the EDEN project[3] once made public.[4]

The CSA will deliver the first version of the catalogue on time for use in the implementation of Part b). The participants in the CSA will provide commercial and other services enabling access to the global market for the results of the RIA selected for support under Part b). The CSA will report publicly on its discussions, and assess and provide feedback on the impact of the business deals implemented with the research and innovation activities led by SMEs under Part b) of this topic.

Part b) (2017): Several RIA aiming at research and development of novel CBRN technologies and innovations identified in the above-mentioned catalogue will be selected by the European Commission. Each of these actions will be led by an SME. Each consortium implementing such a RIA must not only establish a consortium agreement among its members, but also a collaboration agreement with the participants in the CSA supported through Part a). Such a collaboration agreement must settle how the results from the RIA will be exploited and integrated into platforms managed by the CSA.

The outcome of the proposal is expected to lead to development up to Technology Readiness Level (TRL) 4 to 7 for the RIA under part b); please see part G of the General Annexes.

Indicative budget: The Commission considers that proposals requesting a contribution from the EU of about € 2 million per action in 2016 and about € 3.5 million per action in 2017 would allow for this topic to be addressed appropriately. Nonetheless this does not preclude submission and selection of proposals requesting other amounts.

The following options of the Model Grant Agreement will be implemented:

For grants awarded under this topic SEC-05-DRS-05-2016-2017 part a), beneficiaries will be subject to the following additional obligations aiming to ensure exploitation of its results: the CSA must commit to issue: at months 3 and 9 each year, during at least four years of activities, the catalogue of technologies mentioned in the scope of this topic and to make it available upon request; at month 6 each year, the reports of their discussions; and at month 12 each year, the above-mentioned assessment of impact. The respective option on additional exploitation obligations of Article 28.1 of the Model Grant Agreement will be applied. For grants awarded under this topic SEC-05-DRS-05-2016-2017 part b) option 1 of Article 41.3 of the Model Grant Agreement will be applied. Grants awarded under this topic SEC-05-DRS-05-2016-2017 part a) will be complementary to the grant agreements under SEC-05-DRS-05-2016-2017 part b). The respective options of Article 2 and Article 41.4 of the Model Grant Agreement[5] will be applied Grants awarded under this topic SEC-05-DRS-05-2016-2017 part b) will be complementary to the grant agreement under SEC-05-DRS-05-2016-2017 part a). The respective options of Article 2, Article 31.6 and Article 41.4 of the Model Grant Agreement[5] will be applied
Expected Impact: Shorter time to market for novel CBRN technologies and innovations, and more business deals leading to industrial products of interest to more practitioners in Europe (and world-wide). The larger the number of European companies involved in the CSA, the higher its impact will be.


Delegation Exception Footnote:In 2016 only, this activity directly aimed at supporting the development and implementation of evidence base for R&I policies and supporting various groups of stakeholders is excluded from the delegation to the Research Executive Agency and will be implemented by the Commission services.


[1]See Model Grant Agreement

[2]http://ec.europa.eu/programmes/horizon2020/en/news/innovfin-%E2%80%93-eu-finance-innovators-new-financial-instruments-help-innovative-firms-access-finance

[3]https://www.eden-security-fp7.eu/

[4]The catalogue can be found here – please check for updates by 15 April: http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/h2020-sec-tech-catalogue_en.pdf

[5]http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/amga/h2020-amga_en.pdf

[6]http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/amga/h2020-amga_en.pdf

ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: Specific Challenge:Technologies and innovations in the field of CBRN are developed by SMEs or larger companies which often face difficulties in bringing them to markets: because they address local, small niche markets; or because these SMEs have neither the capabilities nor the strategic objective to go for foreign markets; or because the individual technologies that they develop can make it to the market only if integrated and combined with other tools by other companies that have the capabilities and the strategy to market its products abroad, and possibly on the global market. Specific Challenge:Technologies and innovations in the field of CBRN are developed by SMEs or larger companies which often face difficulties in bringing them to markets: because they address local, small niche markets; or because these SMEs have neither the capabilities nor the strategic objective to go for foreign markets; or because the individual technologies that they develop can make it to the market only if integrated and combined with other tools by other companies that have the capabilities and the strategy to market its products abroad, and possibly on the global market.
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Purchase costs.
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
Subcontracting costs.
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Amortizaciones.
Activos.
Otros Gastos.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 5:. Los elementos básicos de la innovación son integrados de manera que la configuración final es similar a su aplicación final, es decir que está listo para ser usado en la simulación de un entorno real. Se mejoran los modelos tanto técnicos como económicos del diseño inicial, se ha identificado adicionalmente aspectos de seguridad, limitaciones ambiéntales y/o regulatorios entre otros. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Please read carefully all provisions below before the preparation of your application.
 
The catalogue containing the list of technologies as referred to in the topic description of the work programme stemming from part a) of the topic can be found under the following link: Catalogue of Technologies
 
As specified in the additional eligibility and admissibility conditions a draft of the "Collaboration Agreement" must be attached to the RIA proposal, and endorsed by at least one participant in the CSA supported through Part a), project 740450 ENCIRCLE.
To facilitate the creation of this draft a template for the collaboration agreement can be found under the following link: Template Collaboration Agreement ENCIRCLE
 
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan).
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme, with the following exceptions:
 
For part b) (2017): each RIA must establish a "Collaboration Agree...
Please read carefully all provisions below before the preparation of your application.
 
The catalogue containing the list of technologies as referred to in the topic description of the work programme stemming from part a) of the topic can be found under the following link: Catalogue of Technologies
 
As specified in the additional eligibility and admissibility conditions a draft of the "Collaboration Agreement" must be attached to the RIA proposal, and endorsed by at least one participant in the CSA supported through Part a), project 740450 ENCIRCLE.
To facilitate the creation of this draft a template for the collaboration agreement can be found under the following link: Template Collaboration Agreement ENCIRCLE
 
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan).
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme, with the following exceptions:
 
For part b) (2017): each RIA must establish a "Collaboration Agreement" with participant(s) in the CSA. A draft of the "Collaboration Agreement" must be attached to the RIA proposal, and endorsed by at least one participant in the CSA.
All beneficiaries of the RIA grant agreements must be independent from each beneficiary in the CSA.
Each RIA proposals must be coordinated by an SME.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
 
Evaluation
3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.
3.2 Submission and evaluation process: Guide to the submission and evaluation process
   
Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
 
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Research and Innovation Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
H2020 General MGA -Multi-Beneficiary
Annotated Grant Agreement
Coordination and Support Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
H2020 General MGA -Multi-Beneficiary
Annotated Grant Agreement
 
Additional provisions:
Horizon 2020 budget flexibility
Classified information
Technology readiness levels (TRL) – where a topic description refers to TRL, these definitions apply.
Financial support to Third Parties – where a topic description foresees financial support to Third Parties, these provisions apply.
 
Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
 
Additional documents
H2020 Work Programme 2016-17: Introduction
H2020 Work Programme 2016-17: Innovation in SMEs
H2020 Work Programme 2016-17: Secure societies – protecting freedom and security of Europe and its citizens
H2020 Work Programme 2016-17: Fast Track to Innovation Pilot
H2020 Work Programme 2016-17: Dissemination, Exploitation and Evaluation
H2020 Work Programme 2016-17: General Annexes
Legal basis: Horizon 2020 - Regulation of Establishment
Legal basis: Horizon 2020 Rules for Participation
Legal basis: Horizon 2020 Specific Programme
Catalogue of Technologies
Template Collaboration Agreement ENCIRCLE
 
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda tiene efecto incentivador, por lo que el proyecto no puede haberse iniciado antes de la presentación de la solicitud de ayuda. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
El presupuesto total de la convocatoria asciende a
Presupuesto total de la convocatoria.
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
H2020-SEC-2016-2017 Chemical, biological, radiological and nuclear (CBRN) cluster Specific Challenge:Technologies and innovations in the field of CBRN are developed by SMEs or larger companies which often face difficulties...
Sin info.
SEC-05-DRS-2016-2017 Chemical, biological, radiological and nuclear (CBRN) cluster
en consorcio: Specific Challenge:Technologies and innovations in the field of CBRN are developed by SMEs or larger companies which often face difficulties...
Cerrada hace 8 años | Próxima convocatoria prevista para el mes de